ArticleInternational journal of cancer2011

Rapamycin enhances the activity of oncolytic herpes simplex virus against tumor cells that are resistant to virus replication.

Xinping Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.